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Abstract
Background: Extracorporeal membrane oxygenation (ECMO) delivers cardiac and/or
respiratory support to critically ill patients who have failed conventional medical
therapies. If the large-bore cannulas used to deliver ECMO become infected or
dislodged, the patient consequences can be catastrophic. ECMO cannula-related
infection has been reported to be double the rate of other vascular devices (7.1 vs 3.
4 episodes/1000 ECMO days respectively). The aim of this study was to assess the
ability of cyanoacrylate tissue adhesive (TA) to inhibit bacterial growth at the ECMO
cannulation site, and the effectiveness of TA and securement devices in securing
ECMO cannulas and tubing.
Methods: This in vitro study tested the (1) antimicrobial qualities of TA against
standard transparent dressing with ECMO cannula; (2) chemical compatibility
between cannula, TA and removal agent; (3) pull-out strength of transparent
dressing and TA at the cannula insertion site; and (4) pull-out strength of adhesive
bandage and commercial sutureless securement devices (SSDs) on circuit tubing.
Fisher’s exact test was used to evaluate differences in bacterial growth observed
between the transparent dressing and TA groups. Data from mechanical testing
were analysed using one-way ANOVA, followed by Tukey’s multiple comparison test
or t test as appropriate. Statistical significance was defined as p < 0.05.
Results: No bacterial growth occurred under TA-covered cannulas compared with
transparent dressing-covered cannulas (p = 0.002). Compared to plates lacking TA or
transparent dressing, growth was observed at the insertion point and under the
dressing in the transparent dressing group; however, no growth was observed in the
TA group (p = 0.019). TA did not weaken the cannulas; however, the TA removal
agent did after 60 min of exposure, compared with control (p < 0.01). Compared
with transparent dressing, TA increased the pull-out force required for cannula
dislodgement from the insertion point (p < 0.0001). SSDs significantly increased the
force required to remove the tubing from the fixation points compared with
adhesive bandage (p < 0.01).
(Continued on next page)
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Conclusions: Our findings suggest that the combined use of TA at the cannula
insertion site with a commercial device for tubing securement could provide an
effective bedside strategy to prevent or minimise infection and line dislodgement.
Keywords: Extracorporeal membrane oxygenation, Cyanoacrylate, Tissue adhesives,
Securement, Catheter-related infections
Background
Extracorporeal membrane oxygenation (ECMO) is a form of cardiopulmonary bypass
used to support patients with severe cardiac and/or respiratory failure who have failed
maximal conventional medical management [1, 2]. Nosocomial infection is one of the
most frequent and serious complications of ECMO [3, 4]. It is often difficult to treat
[5] and has been reported in up to 64% of ECMO patients [4]. Infections acquired
whilst on ECMO are associated with increased durations of ECMO support and
ventilatory support [3, 4, 6–9], and longer intensive care unit and hospital lengths
of stay [4, 10]. Poorer prognosis has also been reported in the paediatric popula-
tion [11]. ECMO patients are a high-risk group for nosocomial bloodstream infec-
tions, which is partly attributable to the large-bore ECMO cannulas and multiple
standard invasive devices needed to manage these critically ill patients [3, 10].
Bloodstream infection rates on ECMO range from 3 to 19 per 1000 ECMO days
[3, 4, 7, 8, 10]. Less frequently reported but equally important is the risk for
localised cannula infection. ECMO cannula-associated infection prevalence ranges
between 10 and 17% [4, 12, 13], with double the rate of infection associated with
ECMO cannulas compared with other vascular devices (7.1 vs 3.4 episodes/1000
ECMO days respectively) [4].
ECMO lines (i.e. cannulas and associated tubing) are key components of the extra-
corporeal circuit but are associated with a large number of the causes of morbidity.
Effective securement of these lines to a surface, such as the patient’s limb, is necessary
to prevent line movement, malposition or kinking that can precipitate obstruction, low
circuit flow and poor venous return, all of which compromise the effectiveness of sup-
port [14]. Additionally, incorrectly positioned cannulas lead to turbulent blood flow
and cannula ‘kicking’, thereby increasing the risk of haemolysis and renal dysfunction
[15]. More serious complications involve partial or complete cannula dislodgement
with resultant rapid loss of ECMO support, air entrainment or catastrophic bleeding
[16]. Line movement may also lead to local infection and bloodstream infection by
facilitating cannula micromotion with the entry of skin-borne organisms through the
insertion site or along the cannula into the bloodstream, as occurs with smaller intra-
vascular catheters [17, 18]. Routine removal or re-siting of contaminated ECMO lines
is not feasible and may be dangerous to the patient [19], and the clinician is sometimes
forced into the scenario of premature termination of ECMO support due to cannula
site infection. Therefore, adequate securement is paramount in preventing line compli-
cations and maintaining ECMO support for its intended duration.
Despite the universal acceptance of the importance of ECMO cannula securement, there
are currently no data on best practice for the effective dressing and securement of ECMO
cannulas. Currently, in many centres, ECMO cannula sites are covered with transparent
Bull et al. Intensive Care Medicine Experimental  (2018) 6:6 Page 2 of 12
dressings to protect the site from extrinsic contamination. Securement methods to stabilise
ECMO lines and prevent gross movement include tapes, adhesive bandages and sutures,
although practice lacks standardisation and no evidence-based recommendations exist.
Commercial sutureless securement devices (SSDs) provide a more contemporary approach
to ECMO line management at the bedside. However, there is mixed evidence regarding
their efficacy in securing intravascular catheters [20, 21] and SSDs have never been tested
with ECMO cannulas. Medical-grade skin glue (cyanoacrylate), also known as tissue
adhesive (TA), has undergone recent investigation as a novel product for securing invasive
devices [18, 20, 22–27] and reducing associated infection risk [25, 28, 29]. TA applications
for improved intravascular catheter securement compared with transparent dressing in-
clude epidural [26], central venous [27], peripheral venous [22, 25] and arterial catheters
[23, 24]. TA also has antimicrobial properties and in vitro testing small-gauge catheters has
shown inhibition of Gram-positive organisms, suggesting its potential to reduce the
incidence of catheter-associated infection [25, 29].
To date, there has been no published research on ECMO line securement, and TA is
untested in large-bore intravascular devices such as ECMO cannulas. We hypothesised
that TA could improve ECMO cannula securement and inhibit bacteria at the cannula
site. Given the imperative to prevent ECMO line complications, we tested in vitro the
safety and feasibility of TA to prevent bacterial colonisation of cannula sites and for
cannula site securement when compared with transparent dressing. We additionally
compared adhesive bandage and two commercial SSDs for sutureless ECMO tubing
securement.
Methods
This study comprised four parts: (1) assessment of microbiological qualities of TA
against standard transparent dressing at the ECMO cannula insertion site; (2) assess-
ment of chemical compatibility between cannula, TA and a TA removal agent; (3) com-
parison of pull-out strength between transparent dressing and TA at the cannula
insertion site; and (4) comparison of pull-out strength between adhesive bandage
securement and commercial sutureless securement devices on ECMO circuit tubing.
Microbiological tests
The ability of TA (Histoacryl; Butyl-cyanoacrylate; B. Braun, Tuttlingen, Germany) and
transparent dressing (Opsite Incise Drape; Smith & Nephew, London, UK) to inhibit
Staphylococcus epidermidis (S. epidermidis RB02) migration and colonisation of ECMO
cannulas was investigated using methods previously described [25]. The S. epidermidis
RB02 used was an isolate from a clinical specimen previously used in similar assays by
our team [25]. Briefly, sterile 23F Bio-Medicus femoral (Medtronic Inc., Minneapolis,
MN) wirewound polyurethane venous cannulas were cut into 5-cm lengths, and each
length was aseptically inserted at an angle approximately 30° into an agar plate contain-
ing the pH indicator bromocresol purple [30]. The cannula plates were separated into
three groups, each group comprising of six replicate plates (n = 6). Group 1 had trans-
parent dressing (Opsite, 7 cm × 7 cm) covering the insertion point; group 2 had TA
(Histoacryl, 0.5 mL) applied at the insertion point and allowed to dry; group 3 was
treated with both TA and transparent dressing. TA and transparent dressings were
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applied according to the manufacturer’s instructions. Unsecured cannulas lacking trans-
parent dressing or TA were used as controls (n = 3).
A 10-μL aliquot of a S. epidermidis RB02 suspension was applied at the edge of the TA
or transparent dressing, or the dressing only for the combined TA and transparent dress-
ing tests. Control plates had the bacteria seeded on the cannula entry point. The bacterial
suspension was allowed to dry and was incubated overnight at 37 °C. The plates were
scored for bacterial growth every 24 h up to 72 h. The presence of bacterial growth was
determined by pH indicator dye which changes colour from purple (pH 6.8) to yellow
(pH 5.2) when the bacteria ferment glucose in the media and produce acid.
Chemical compatibility tests
To test chemical compatibility of TA and TA removal agent with ECMO cannulas, 23F
Bio-Medicus femoral (Medtronic Inc., Minneapolis, MN) venous cannulas were cut
into 15-cm lengths. The central 1-cm cannula section was exposed to Histoacryl or
Remove (Smith & Nephew, Mississauga, ON) adhesive remover wipe per manufacturer
instructions for 15 or 60 min (n = 6 per group per exposure time). All cannula sections
were then subjected to mechanical testing to measure tensile strength; this was per-
formed using an Instron 5567 (Instron Pty Ltd., High Wycombe, UK) universal testing
machine at a crosshead speed of 250 mm/min. The force (N) needed to produce break-
age of the cannula was recorded for every test of each group.
Cannula securement (insertion site) tests
Adult porcine skin for testing of securement methods was obtained immediately fol-
lowing euthanasia of the animal. Skin sections measuring 13 cm × 20 cm were cut from
a standard area of the animal then washed and dried with paper towel followed by hair
removal using a surgical clipper. For each test, the skin section was attached by the
edges to a purpose-built metal frame. A simulated ECMO cannula site was created
using a modified Seldinger technique; a small incision was made in the centre of the
skin section using a scalpel blade, and then, a 15-cm section of a Bio-Medicus Femoral
21F venous cannula was inserted through the incision following serial dilatation, allow-
ing the hole to accommodate the cannula whilst ensuring a tight fit. For the TA test
group, the cannula was secured with 0.5 mL of Histoacryl placed around the cannula
insertion point and along the cannula to the end of the skin section (~ 7 cm), and
allowed to dry for 30 min (Fig. 1a). For the transparent dressing test group, non-glued
Fig. 1 Simulated ECMO cannula insertion site. Cannula secured with a tissue adhesive, Histoacryl (n = 6),
and b transparent dressing, Opsite (n = 6)
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cannulas were covered with a single layer of Opsite cut to size (10 cm × 17 cm) and left
untouched for 5 min after application (Fig. 1b). Six tests were performed for each
group. In each test case, the metal frame containing the simulated cannula site was
mounted onto the tensile testing machine (Instron 5567) and the pull-out force was
measured (tensile force required to produce bond failure under the same conditions as
described in ‘Chemical compatibility tests’).
Tubing securement tests
Circuit tubing tests were undertaken using porcine skin sections prepared, framed and
mounted according to the same method as described above. A simulated ECMO line se-
curement point was created using 20-cm lengths of 3/8-in.-diameter tubing (Medtronic
Inc., Minneapolis, MN) secured to the skin in three different groups (n = 6 for each
group). Group 1 was secured with large-sized Grip-lok Universal Securement Device
(TIDI Products, Neenah, WI) (Fig. 2a); group 2 was secured with a large-sized MultiFix
UniFix Universal Tube and Catheter Securement Band (Midmed Pty Ltd., Murrarie,
QLD, Australia) (Fig. 2b); and group 3 was secured to the skin with Tensoplast (BSN
Medical, Mt. Waverley, VIC, Australia) elastic adhesive bandage using the method
employed at our institution (Fig. 2c): Friars’ Balsam (LCM Ltd., Huddersfield, UK) was
wiped onto the skin using a gauze pad and allowed to dry (to make the skin ‘tacky’ and
improve adhesion of bandage to the skin); the elastic bandage was stuck onto the skin
(along one side of the tubing), looped around the full circumference of the tubing, then
stuck to the skin on the opposite side of the looped tape; the bandage was then anchored
around the tubing using sutures placed through and around the tape loop (avoiding sutur-
ing of the skin) at three points along the tape section to prevent the bandage lifting away
from the tubing.
Statistical analysis
All statistical analyses were performed using Prism 6.0 (Graphpad Software Inc.).
Sample size calculations were based on similar testing previously reported [25]. Fisher’s
exact test was used to statistically evaluate differences in bacterial growth observed
between the transparent dressing and TA groups (microbiological tests). All data from
mechanical testing (chemical campatibility, cannula securement, and tubing secure-
ment tests) were analysed using one-way ANOVA, followed by Tukey’s multiple com-
parison test or t test as appropriate. Statistical significance was defined as p < 0.05.
Fig. 2 Skin with ECMO tubing attached and secured. a Grip-lok (n = 6). b MultiFix (n = 6). c Tensoplast
adhesive bandage (n = 6)
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Results
Microbiological tests
At 24 h post-inoculation, bacterial growth was not observed in any TA test plates
(Fig. 3b) whereas bacterial growth was present under the dressing in all transparent
dressing test plates (Fig. 3c) (p = 0.002). TA also prevented penetration of bacteria at
the cannula insertion point and along the tunnel (in agar) in all tests, when compared
with control plates (p = 0.019). Bacterial migration to the insertion point did not differ
between control and dressing plates with transparent dressing offering no protection
from this occurrence (p = 0.167). In the combined dressing and TA test plates (Fig. 3d),
TA inhibited migration of bacterial growth to the cannula insertion point and along the
tunnel with bacterial growth observed only under the transparent dressing. Table 1
indicates the presence or absence of bacterial growth after 72 h of observation.
Chemical compatibility tests
Compared with control, cannula tensile strength was not reduced with the TA (132 vs
128 N) or TA remover agent (132 vs 134 N) at the 15-min exposure time (p = 0.57).
However, increasing the TA remover agent exposure time to 1 h significantly weakened
the cannula (132 vs 87 N, p < 0.01).
Cannula securement (insertion site) tests and tubing securement tests
TA significantly increased the pull-out force required to remove the cannula from the
skin when compared with transparent dressing (62.8 vs 15.2 N, p < 0.0001; Fig. 4a). The
force required to remove the tubing from the skin with both Grip-lok device (92.0 N)
and MultiFix device (94.8 N) was very similar and was significantly increased compared
with Tensoplast adhesive bandage (56.2 N) (p < 0.01; Fig. 4b).
Discussion
This in vitro study demonstrated that TA is effective in providing a barrier for the
prevention of bacterial migration to the ECMO cannula insertion site; TA significantly
increases the force required to dislodge the cannula from the insertion site and, when
used in combination with a SSD securing the circuit tubing, could substantially reduce
Fig. 3 Microbiological test results. a Control plate: S. epidermidis growth on pH indicator agar. b TA applied
at insertion site: TA inhibits S. epidermidis growth along the TA edge to the insertion point. c Transparent
dressing applied over insertion site: S. epidermidis growth under the dressing, at the cannula insertion point
and along the cannula dressing tunnel. d TA + transparent dressing: S. epidermidis growth under the
dressing but inhibited beyond the TA edge. TA, tissue adhesive
Bull et al. Intensive Care Medicine Experimental  (2018) 6:6 Page 6 of 12
the risk of accidental cannula movement and dislodgement. We found that TA pre-
vented bacterial migration to the site of insertion and along the cannula tunnel, alone
or in combination with transparent dressing. Additionally, TA was shown to be a super-
ior option for ECMO cannula securement when compared to transparent dressing,
which is commonly used to dress and secure cannulas at the point of percutaneous
insertion. We established that the two commercial SSDs were more efficacious than the
adhesive bandage method (Tensoplast) used at our institution to secure ECMO circuit
tubing. Our findings suggest that TA may be useful in the bedside management of
ECMO lines, both to prevent or minimise the potential for infection and to improve
sutureless line securement.
To our knowledge, TA has not been tested as a bacterial inhibitor with ECMO can-
nulas. The complete capacity of TA to prevent bacterial migration in this in vitro study
has significant potential in the clinical setting. When used to seal the ECMO cannula
insertion site, TA effects may reduce extraluminal contamination via a bactericidal
effect or a physical barrier effect on bacterial translocation at the skin puncture [29].
Therefore, TA has the potential to reduce localised and bloodstream infection in
ECMO, and subsequently may decrease ICU stays, hospital stays and healthcare costs.
Our results also showed that neither TA nor TA remover wipe (Remove wipes)
applied for 15 min weakened the cannula. However, exposure to TA remover wipe
weakened the cannula after 60 min; therefore, all residual products must be removed
from the ECMO cannula after TA removal. Avoiding prolonged contact and thoroughly
wiping the area with normal saline to remove TA remover wipe residue must be key
elements of cannula site care protocols. The manufacturer’s instructions regarding the
Table 1 S. epidermidis growth surrounding ECMO cannulas and securement product at 72 h
post-inoculation
Securement product Edge of securement
product
Underneath securement
product
Cannula insertion
point
Along cannula
tunnel
Histoacryl (n = 6) + − − −
Opsite (n = 6) + + + +
Histoacryl and Opsite (n = 6) − (Histoacryl)
+ (Opsite)
− (Histoacryl)
+ (Opsite)
− −
Unsecured (n = 3) N/A N/A + +
“+” growth at 72 h, “−” absence of growth at 72 h
Fig. 4 Mechanical test results. a Cannula securement comparing transparent dressing (Opsite) with TA
(Histoacryl). b Tubing securement comparing adhesive bandage (Tensoplast) with SSD (Grip-lok and
MultiFix). TA, tissue adhesive; SSD, sutureless securement device
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removal of TA (Histoacryl) state that acetone may be used to remove residual product;
however, this was not tested in this study as the investigators felt it would be inappro-
priate to use acetone on the cannulation site.
In testing the securement properties of TA at the site of cannula insertion, we found
TA to be significantly stronger than transparent dressing. Other research shows TA to
be a promising novel solution for intravascular device securement [18, 20, 23, 24].
Compared with transparent dressing, TA may have benefits in reduced ECMO cannula
migration, as well as reduced infection risk by limiting pistoning or micromotion of the
cannula and subsequent introduction of bacteria [17, 18]. Its clinical application would
be advantageous for femoral cannulas given that peripheral cannulation for ECMO
commonly involves the femoral vessels [31] and this location is a greater risk factor for
colonisation and/or bloodstream infection compared with internal jugular sites in
adults [32]. With regard to securement of the ECMO tubing, both of the commercial
SSDs tested were significantly stronger than the method using adhesive bandage
(Tensoplast). The greater tensile strength and therefore ability to limit gross line move-
ment suggests SSDs could offer a safer clinical approach to reducing the risk of acutely
life-threatening or fatal outcomes of accidental decannulation [33, 34]. SSDs have
undergone limited clinical testing, but they appear safe, feasible and acceptable for cen-
tral catheters [20]. The benefits of SSDs and TA in ECMO are summarised in Table 2.
The current study suggests that TA is a promising, simple alternative to traditional
dressing methods and suturing which is itself associated with infection risk. We
propose that the combined use of TA at the insertion site with SSDs along the ECMO
tubing provides a feasible line management strategy which can be easily implemented
at the bedside to prevent complications. Our findings have particular relevance to cen-
tres performing peripheral cannulation by percutaneous Seldinger technique since a
key rationale of this practice is to avoid skin suturing and reduce insertion site bleeding
[16, 35]. Our research highlights the importance of further investigation into the most
effective methods for sutureless securement in this context, especially with the trend to
increase patient mobility on ECMO [36, 37]; the need to transfer these patients for
scanning or procedures; and the preference for multiport drainage cannulas which can
rapidly entrain air through side holes should outward migration from the vessel occur
[38]. A targeted research program investigating dressing and securement options is vital
in providing valuable evidence to guide global practice in this area.
There were limitations to this study. Firstly, we tested only S. epidermidis due to its
association with bloodstream infection during ECMO and its reported association with
culture confirmed ECMO cannula infection [4]. We tested S. aureus in a previous la-
boratory study with the same results as S. epidermidis [25]. Secondly, microbiological
and mechanical testing was performed using only one type of TA (butyl-cyanoacrylate)
as our previous testing [25] demonstrated its superiority over octyl-cyanoacrylate.
Thirdly, mechanical testing of the cannulas and tubing was performed separately rather
than together as one continuous ECMO line. There are limitations in testing two
mechanical systems in series, due to different strengths, inevitably that the load will
not be shared evenly between the two sites, meaning one will always fail before the
other at a similar failure force of that part on its own. Lastly, the use of TA to secure
ECMO cannulas would not be appropriate for central ECMO cannulations therefore
our findings could only be generalisable to peripheral cannulations.
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Conclusions
TA appears promising as a simple infection prevention and adjunct securement method
for ECMO lines. Moreover, the combined use of TA at the cannula entry point with a
sutureless device for tubing securement could provide an optimal overall strategy for line
stabilisation, with the potential to reduce ECMO line-associated complications. A suffi-
ciently powered randomised controlled trial will determine if the pre-clinical findings
reported here translate into an effective strategy to reduce cannula-associated infection
and cannula malposition or dislodgement.
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